[Effect of Tavegyl (Polfa) on microorganisms detected in otocenosis during in vivo studies].
D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy*; D002974:Clemastine / Q000627:therapeutic use*; D004432:Ear, Middle / Q000382:microbiology*; D005658:Fungi / Q000187:drug effects; D006801:Humans; D009181:Mycoses / Q000188:drug therapy*; D010033:Otitis Media / Q000188:drug therapy*; D010034:Otitis Media with Effusion / Q000188:drug therapy*; D011759:Pyrrolidines / Q000627:therapeutic use*
D011759:Pyrrolidines; D002974:Clemastine
Wpływ preparatu Tavegyl (Polfa) na mikroorganizmy wykrywane w otocenozie ucha w badaniach in vivo.